Initial Clinical Experience with [177Lu]Lu-RTX-2358 Radiopharmaceutical Therapy Targeting Fibroblast Activation Protein: Biodistribution, Pharmacokinetics, and Dosimetry.
Saved in:
| Title: | Initial Clinical Experience with [177Lu]Lu-RTX-2358 Radiopharmaceutical Therapy Targeting Fibroblast Activation Protein: Biodistribution, Pharmacokinetics, and Dosimetry. |
|---|---|
| Authors: | Glantschnig, Lisa1 (AUTHOR), Enke, Johanna S.1,2 (AUTHOR), Schuller, Bradley W.3 (AUTHOR), Fenn, Eric J.3 (AUTHOR), Dierks, Alexander1 (AUTHOR), Patt, Marianne1 (AUTHOR), Rinscheid, Andreas4 (AUTHOR), Seifert, Robert5 (AUTHOR), Unterrainer, Lena M.6 (AUTHOR), Lindner, Lars H.7 (AUTHOR), Di Gioia, Dorit7 (AUTHOR), Babich, John W.3 (AUTHOR), Amor Coarasa, Alejandro3 (AUTHOR), Friebe, Matthias3 (AUTHOR), Hesterman, Jacob Y.3 (AUTHOR), Bundschuh, Ralph A.1,8 (AUTHOR), Lapa, Constantin1,2 (AUTHOR) constantin.lapa@uk-augsburg.de |
| Source: | Journal of Nuclear Medicine. May2026, Vol. 67 Issue 5, p709-716. 8p. |
| Database: | Engineering Source |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 01615505 |
|---|---|
| DOI: | 10.2967/jnumed.125.271031 |
